Michael R Mulvey Jennifer M Grant Katherine Plewes Diane Roscoe David A Boyd
10.3201/eid1701.101358
Emerg Infect Dis
2011 Jan;17(1):103-6.
CC BY
https://pubmed.ncbi.nlm.nih.gov/21192866/
Drug Resistance, Multiple, Bacterial Escherichia coli / drug effects Escherichia coli Infections / epidemiology Klebsiella Infections / epidemiology Klebsiella pneumoniae / drug effects beta-Lactamases / genetics beta-Lactamases / metabolism
Drug Resistance, Multiple, Bacterial Escherichia coli / drug effects Escherichia coli Infections / epidemiology Klebsiella Infections / epidemiology Klebsiella pneumoniae / drug effects beta-Lactamases / genetics beta-Lactamases / metabolism Case Reports Aged Anti-Bacterial Agents / pharmacology Canada / epidemiology Escherichia coli / enzymology Escherichia coli / genetics Escherichia coli / isolation & purification Escherichia coli Infections / microbiology Fatal Outcome Female Humans India Klebsiella Infections / microbiology Klebsiella pneumoniae / enzymology Klebsiella pneumoniae / genetics Klebsiella pneumoniae / isolation & purification Microbial Sensitivity Tests Plasmids Travel Anti-Bacterial Agents beta-Lactamases beta-lactamase NDM-1
PMC3204653
21192866
New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada
2011